Skip to content

Haiyi Jiang

Institut Gustave Roussy

2 papers in the Anchorcite directory, published between 2009 and 2017, cited 13,070 times in total.

ORCID profile

Research topics

Frequent co-authors

  • Tony S.K. Mok · 1 paper
  • Yi-Long Lung Cancer Wu · 1 paper
  • Sumitra Thongprasert · 1 paper
  • Da-Tong Chu · 1 paper
  • Nagahiro Saijo · 1 paper
  • Patrapim Sunpaweravong · 1 paper
  • Baohui Han · 1 paper
  • Benjamin Palgunadi Margono · 1 paper

Papers

  1. Gefitinib or Carboplatin–Paclitaxel in Pulmonary AdenocarcinomaNew England Journal of Medicine · 2009 · 8,355 citations

    BACKGROUND: Previous, uncontrolled studies have suggested that first-line treatment with gefitinib would be efficacious in selected patients with non-small-cell lung cancer. METHODS: In this phase 3, open-label study, we randomly assigned previously untreated patients in East Asia who had advanced…

  2. Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung CancerNew England Journal of Medicine · 2017 · 4,715 citations

    BACKGROUND: Most patients with locally advanced, unresectable, non-small-cell lung cancer (NSCLC) have disease progression despite definitive chemoradiotherapy (chemotherapy plus concurrent radiation therapy). This phase 3 study compared the anti-programmed death ligand 1 antibody durvalumab as consolidation therapy with placebo in…

Metadata from OpenAlex (CC0).